Analysed BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) News Sources
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
07-11-2025
yahoo.com
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
02-12-2025
yahoo.com
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
19-03-2026
yahoo.com
Biofrontera Inc (BFRI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
21-03-2026
yahoo.com
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
08-05-2026
yahoo.com
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
13-05-2026
yahoo.com
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
14-05-2026
yahoo.com
What is the current price of BIOFRONTERA INC -CW26 (BFRIW:NASDAQ)?
The current price of BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) is $0.0314.
BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) since the previous trading day is $0.005.
BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) since the previous trading day is 18.9394%.
What is the most recent average sentiment score for BIOFRONTERA INC -CW26 (BFRIW:NASDAQ)?
The most recent average sentiment score for BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for BIOFRONTERA INC -CW26 (BFRIW:NASDAQ)?
The most recent sentiment for BIOFRONTERA INC -CW26 (BFRIW:NASDAQ) is .
SEC-8K** Filing Available For BIOFRONTERA INC -CW26 (BFRIW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.